Does routine home visiting improve the return rate and outcome of DOTS patients who delay treatment?

Eastern Mediterranean Health Journal

Volumn 9, Issue 4, 2003, Pages 702-708

  Mohan, A ^a   Nassir, H ^b   Niazi, A ^c  

^a MINISTRY OF HEALTH   (Iraq)

^b UNIVERSITY OF BAGHDAD   (Iraq)

^c Al Nahrain University College of Medicine   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEALTH CARE PERSONNEL; HOME CARE; HUMAN; IRAQ; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT EDUCATION; PROFESSIONAL PRACTICE; RANDOMIZED CONTROLLED TRIAL; REGISTER; SHORT COURSE THERAPY; SPUTUM SMEAR; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTITUBERCULAR AGENTS; CHI-SQUARE DISTRIBUTION; DIRECTLY OBSERVED THERAPY; DISEASE NOTIFICATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOME CARE SERVICES; HOUSE CALLS; HUMANS; IRAQ; LOGISTIC MODELS; MOTIVATION; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT DROPOUTS; PROGRAM EVALUATION; PUBLIC HEALTH PRACTICE; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; URBAN HEALTH SERVICES; VOLUNTARY WORKERS;

EID: 16844380137     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Use DOTS more widely: WHO report on the tuberculosis epidemic 1997. Geneva, WHO, 1997 (WHO/TB/97.224).
2. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle, 1991, 72:1-6.
3. Bass JB. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and the Centers for Disease Control and Prevention. American journal of respiratory and critical care medicine, 1994, 149: 1359-74.
4. White AJ, Robinson-White CM, Luitel H. A report on home visiting practices conducted in remote districts of Nepal in an NGO-run tuberculosis control programme. International journal of tuberculosis and lung disease, 1999, 3(6): 534-6.
5. Zellweger JP, Coulon P. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. International journal of tuberculosis and lung disease, 1998, 2(5):372-7.
6. O'Boyle SJ et al. Factors affecting patient compliance with anti-tuberculosis chemotherapy using directly observed treatment, short-course strategy (DOTS). International journal of tuberculosis and lung disease, 2002, 6(4):307-12.
7. MOH report on tuberculosis in Iraq, 1999. TB annual report Baghdad, Iraq, Ministry of Health, 1999
8. Fox W. Self-administration of medicaments. A review of published work and study of the problem. Bulletin of the International Union against Tuberculosis, 1962, 32:307-31.
9. Rouillon A. Problems raised by the organization of an efficient ambulatory treatment for tuberculous patients. Bulletin of the International Union against Tuberculosis, 1972, 47:72-87.
10. Wilkinson D. Eight years of tuberculosis research in Hlabisa - what have we learned? South African medical journal, 1999, 89(2):155-9.
11. Weis SE. Universal directly observed therapy. A treatment strategy for tuberculosis. Clinics in chest medicine, 1994, 18:155-63.
12. Iseman MD. Directly observed therapy, patient education and combined drug formulations: complementary, not alternative, strategy in tuberculosis control. Tubercle and lung disease, 1996, 77: 101.
13. Salomon N et al. Implementation of universal directly observed therapy at a New York City hospital and evaluation of an out-patient directly observed therapy program. International journal of tuberculosis and lung disease, 1997, 1:397-404.
14. Caminero JA et al. Evaluation of a directly observed six months fully intermittent treatment regimen for tuberculosis in patients suspected of poor compliance. Thorax, 1996, 51:1130-3.
15. Jin BW et al. The impact of intensified supervisory activities on tuberculosis treatment. Tubercle and lung disease, 1993, 74:267-72.
16. China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet, 1996, 347:358-62.